Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 341

1.

A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].

Garrison LP Jr, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC.

Value Health. 2018 Feb;21(2):161-165. doi: 10.1016/j.jval.2017.12.009.

PMID:
29477394
2.

Trading Bankruptcy for Health: A Discrete-Choice Experiment.

Shrime MG, Weinstein MC, Hammitt JK, Cohen JL, Salomon JA.

Value Health. 2018 Jan;21(1):95-104. doi: 10.1016/j.jval.2017.07.006. Epub 2017 Sep 1.

PMID:
29304947
3.

Association Between Medicare Expenditure Growth and Mortality Rates in Patients With Acute Myocardial Infarction: A Comparison From 1999 Through 2014.

Likosky DS, Van Parys J, Zhou W, Borden WB, Weinstein MC, Skinner JS.

JAMA Cardiol. 2018 Feb 1;3(2):114-122. doi: 10.1001/jamacardio.2017.4771.

PMID:
29261829
4.

The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.

Borre ED, Hyle EP, Paltiel AD, Neilan AM, Sax PE, Freedberg KA, Weinstein MC, Walensky RP.

J Infect Dis. 2017 Oct 17;216(7):798-807. doi: 10.1093/infdis/jix349.

PMID:
29029344
5.

Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States.

Reddy KP, Kong CY, Hyle EP, Baggett TP, Huang M, Parker RA, Paltiel AD, Losina E, Weinstein MC, Freedberg KA, Walensky RP.

JAMA Intern Med. 2017 Nov 1;177(11):1613-1621. doi: 10.1001/jamainternmed.2017.4349.

PMID:
28975270
6.

Understanding the value of minimally invasive procedures for the treatment of lumbar spinal stenosis: the case of interspinous spacer devices.

Tapp SJ, Martin BI, Tosteson TD, Lurie JD, Weinstein MC, Deyo RA, Mirza SK, Tosteson ANA.

Spine J. 2018 Apr;18(4):584-592. doi: 10.1016/j.spinee.2017.08.246. Epub 2017 Aug 25.

PMID:
28847740
7.

Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.

Walensky RP, Borre ED, Bekker LG, Hyle EP, Gonsalves GS, Wood R, EholiƩ SP, Weinstein MC, Anglaret X, Freedberg KA, Paltiel AD.

Ann Intern Med. 2017 Nov 7;167(9):618-629. doi: 10.7326/M17-1358. Epub 2017 Aug 29.

8.

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa.

Paltiel AD, Zheng A, Weinstein MC, Gaynes MR, Wood R, Freedberg KA, Sax PE, Walensky RP.

Open Forum Infect Dis. 2017 Apr 22;4(2):ofx081. doi: 10.1093/ofid/ofx081. eCollection 2017 Spring.

9.

Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States.

Losina E, Hyle EP, Borre ED, Linas BP, Sax PE, Weinstein MC, Rusu C, Ciaranello AL, Walensky RP, Freedberg KA.

Clin Infect Dis. 2017 Oct 15;65(8):1266-1271. doi: 10.1093/cid/cix547.

PMID:
28605504
10.

Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.

Pandya A, Sy S, Cho S, Alam S, Weinstein MC, Gaziano TA.

Med Decis Making. 2017 Oct;37(7):802-814. doi: 10.1177/0272989X17706081. Epub 2017 May 10.

PMID:
28490271
11.

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1.

Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY.

Open Forum Infect Dis. 2016 Dec 27;4(1):ofw266. doi: 10.1093/ofid/ofw266. eCollection 2017 Winter.

12.

Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.

Fust K, Parthan A, Maschio M, Gu Q, Li X, Lyman GH, Tzivelekis S, Villa G, Weinstein MC.

Expert Rev Pharmacoecon Outcomes Res. 2017 Feb;17(1):39-52. doi: 10.1080/14737167.2017.1276829. Epub 2017 Jan 20. Review.

PMID:
28064553
13.

Sustainable Development in Surgery: The Health, Poverty, and Equity Impacts of Charitable Surgery in Uganda.

Shrime MG, Sekidde S, Linden A, Cohen JL, Weinstein MC, Salomon JA.

PLoS One. 2016 Dec 30;11(12):e0168867. doi: 10.1371/journal.pone.0168867. eCollection 2016.

14.

Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma.

Fust K, Li X, Maschio M, Villa G, Parthan A, Barron R, Weinstein MC, Somers L, Hoefkens C, Lyman GH.

Pharmacoeconomics. 2017 Apr;35(4):425-438. doi: 10.1007/s40273-016-0474-0.

15.

Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.

Reddy KP, Parker RA, Losina E, Baggett TP, Paltiel AD, Rigotti NA, Weinstein MC, Freedberg KA, Walensky RP.

J Infect Dis. 2016 Dec 1;214(11):1672-1681. Epub 2016 Nov 3.

16.

Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis.

de Geus SW, Evans DB, Bliss LA, Eskander MF, Smith JK, Wolff RA, Miksad RA, Weinstein MC, Tseng JF.

Eur J Surg Oncol. 2016 Oct;42(10):1552-60. doi: 10.1016/j.ejso.2016.07.016. Epub 2016 Aug 9.

PMID:
27570116
17.

Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency.

Francke JA, Penazzato M, Hou T, Abrams EJ, MacLean RL, Myer L, Walensky RP, Leroy V, Weinstein MC, Parker RA, Freedberg KA, Ciaranello A.

J Infect Dis. 2016 Nov 1;214(9):1319-1328. Epub 2016 Aug 17.

18.

International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework.

Malone DC, Berg NS, Claxton K, Garrison LP Jr, IJzerman M, Marsh K, Neumann PJ, Sculpher M, Towse A, Uyl-de Groot C, Weinstein MC.

J Clin Oncol. 2016 Aug 20;34(24):2936-7. doi: 10.1200/JCO.2015.64.4328. Epub 2016 Jun 13. No abstract available.

PMID:
27298420
19.

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

Walensky RP, Borre ED, Bekker LG, Resch SC, Hyle EP, Wood R, Weinstein MC, Ciaranello AL, Freedberg KA, Paltiel AD.

Ann Intern Med. 2016 Sep 6;165(5):325-33. doi: 10.7326/M16-0799. Epub 2016 May 31.

20.

Aflibercept vs. Ranibizumab: cost-effectiveness of treatment for wet age-related macular degeneration in Sweden.

Panchmatia HR, Clements KM, Hulbert E, Eriksson M, Wittrup-Jensen K, Nilsson J, Weinstein MC.

Acta Ophthalmol. 2016 Aug;94(5):441-8. doi: 10.1111/aos.12964. Epub 2016 Apr 7.

Supplemental Content

Loading ...
Support Center